Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Uric Acid Drug Market Growth 2022-2028

  • LP 4893268
  • 95 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Uric Acid Drug will have significant change from previous year. According to our (LP Information) latest study, the global Uric Acid Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Uric Acid Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Uric Acid Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Uric Acid Drug market, reaching US$ million by the year 2028. As for the Europe Uric Acid Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Uric Acid Drug players cover AstraZeneca plc, Boehringer Ingelheim GmbH, Teijin Pharma Ltd, and Regeneron Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Uric Acid Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Allopurinol

Febuxostat

Probenecid

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Online Pharmacies

Retail Pharmacies

Hospital Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

AstraZeneca plc

Boehringer Ingelheim GmbH

Teijin Pharma Ltd

Regeneron Pharmaceuticals

GlaxoSmithKline plc

Merck & Co. Inc

Novartis AG

Savient Pharmaceuticals

Ironwood Pharmaceuticals

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Uric Acid Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Uric Acid Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Uric Acid Drug by Country/Region, 2017, 2022 & 2028

2.2 Uric Acid Drug Segment by Type

2.2.1 Allopurinol

2.2.2 Febuxostat

2.2.3 Probenecid

2.3 Uric Acid Drug Sales by Type

2.3.1 Global Uric Acid Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Uric Acid Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Uric Acid Drug Sale Price by Type (2017-2022)

2.4 Uric Acid Drug Segment by Application

2.4.1 Online Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Hospital Pharmacies

2.5 Uric Acid Drug Sales by Application

2.5.1 Global Uric Acid Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Uric Acid Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Uric Acid Drug Sale Price by Application (2017-2022)

3 Global Uric Acid Drug by Company

3.1 Global Uric Acid Drug Breakdown Data by Company

3.1.1 Global Uric Acid Drug Annual Sales by Company (2020-2022)

3.1.2 Global Uric Acid Drug Sales Market Share by Company (2020-2022)

3.2 Global Uric Acid Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Uric Acid Drug Revenue by Company (2020-2022)

3.2.2 Global Uric Acid Drug Revenue Market Share by Company (2020-2022)

3.3 Global Uric Acid Drug Sale Price by Company

3.4 Key Manufacturers Uric Acid Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Uric Acid Drug Product Location Distribution

3.4.2 Players Uric Acid Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Uric Acid Drug by Geographic Region

4.1 World Historic Uric Acid Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Uric Acid Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Uric Acid Drug Annual Revenue by Geographic Region

4.2 World Historic Uric Acid Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Uric Acid Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Uric Acid Drug Annual Revenue by Country/Region

4.3 Americas Uric Acid Drug Sales Growth

4.4 APAC Uric Acid Drug Sales Growth

4.5 Europe Uric Acid Drug Sales Growth

4.6 Middle East & Africa Uric Acid Drug Sales Growth

5 Americas

5.1 Americas Uric Acid Drug Sales by Country

5.1.1 Americas Uric Acid Drug Sales by Country (2017-2022)

5.1.2 Americas Uric Acid Drug Revenue by Country (2017-2022)

5.2 Americas Uric Acid Drug Sales by Type

5.3 Americas Uric Acid Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Uric Acid Drug Sales by Region

6.1.1 APAC Uric Acid Drug Sales by Region (2017-2022)

6.1.2 APAC Uric Acid Drug Revenue by Region (2017-2022)

6.2 APAC Uric Acid Drug Sales by Type

6.3 APAC Uric Acid Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Uric Acid Drug by Country

7.1.1 Europe Uric Acid Drug Sales by Country (2017-2022)

7.1.2 Europe Uric Acid Drug Revenue by Country (2017-2022)

7.2 Europe Uric Acid Drug Sales by Type

7.3 Europe Uric Acid Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Uric Acid Drug by Country

8.1.1 Middle East & Africa Uric Acid Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Uric Acid Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Uric Acid Drug Sales by Type

8.3 Middle East & Africa Uric Acid Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Uric Acid Drug

10.3 Manufacturing Process Analysis of Uric Acid Drug

10.4 Industry Chain Structure of Uric Acid Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Uric Acid Drug Distributors

11.3 Uric Acid Drug Customer

12 World Forecast Review for Uric Acid Drug by Geographic Region

12.1 Global Uric Acid Drug Market Size Forecast by Region

12.1.1 Global Uric Acid Drug Forecast by Region (2023-2028)

12.1.2 Global Uric Acid Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Uric Acid Drug Forecast by Type

12.7 Global Uric Acid Drug Forecast by Application

13 Key Players Analysis

13.1 AstraZeneca plc

13.1.1 AstraZeneca plc Company Information

13.1.2 AstraZeneca plc Uric Acid Drug Product Offered

13.1.3 AstraZeneca plc Uric Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AstraZeneca plc Main Business Overview

13.1.5 AstraZeneca plc Latest Developments

13.2 Boehringer Ingelheim GmbH

13.2.1 Boehringer Ingelheim GmbH Company Information

13.2.2 Boehringer Ingelheim GmbH Uric Acid Drug Product Offered

13.2.3 Boehringer Ingelheim GmbH Uric Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Boehringer Ingelheim GmbH Main Business Overview

13.2.5 Boehringer Ingelheim GmbH Latest Developments

13.3 Teijin Pharma Ltd

13.3.1 Teijin Pharma Ltd Company Information

13.3.2 Teijin Pharma Ltd Uric Acid Drug Product Offered

13.3.3 Teijin Pharma Ltd Uric Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Teijin Pharma Ltd Main Business Overview

13.3.5 Teijin Pharma Ltd Latest Developments

13.4 Regeneron Pharmaceuticals

13.4.1 Regeneron Pharmaceuticals Company Information

13.4.2 Regeneron Pharmaceuticals Uric Acid Drug Product Offered

13.4.3 Regeneron Pharmaceuticals Uric Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Regeneron Pharmaceuticals Main Business Overview

13.4.5 Regeneron Pharmaceuticals Latest Developments

13.5 GlaxoSmithKline plc

13.5.1 GlaxoSmithKline plc Company Information

13.5.2 GlaxoSmithKline plc Uric Acid Drug Product Offered

13.5.3 GlaxoSmithKline plc Uric Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 GlaxoSmithKline plc Main Business Overview

13.5.5 GlaxoSmithKline plc Latest Developments

13.6 Merck & Co. Inc

13.6.1 Merck & Co. Inc Company Information

13.6.2 Merck & Co. Inc Uric Acid Drug Product Offered

13.6.3 Merck & Co. Inc Uric Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Merck & Co. Inc Main Business Overview

13.6.5 Merck & Co. Inc Latest Developments

13.7 Novartis AG

13.7.1 Novartis AG Company Information

13.7.2 Novartis AG Uric Acid Drug Product Offered

13.7.3 Novartis AG Uric Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Novartis AG Main Business Overview

13.7.5 Novartis AG Latest Developments

13.8 Savient Pharmaceuticals

13.8.1 Savient Pharmaceuticals Company Information

13.8.2 Savient Pharmaceuticals Uric Acid Drug Product Offered

13.8.3 Savient Pharmaceuticals Uric Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Savient Pharmaceuticals Main Business Overview

13.8.5 Savient Pharmaceuticals Latest Developments

13.9 Ironwood Pharmaceuticals

13.9.1 Ironwood Pharmaceuticals Company Information

13.9.2 Ironwood Pharmaceuticals Uric Acid Drug Product Offered

13.9.3 Ironwood Pharmaceuticals Uric Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Ironwood Pharmaceuticals Main Business Overview

13.9.5 Ironwood Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Uric Acid Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Uric Acid Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Allopurinol

Table 4. Major Players of Febuxostat

Table 5. Major Players of Probenecid

Table 6. Global Uric Acid Drug Sales by Type (2017-2022) & (K Units)

Table 7. Global Uric Acid Drug Sales Market Share by Type (2017-2022)

Table 8. Global Uric Acid Drug Revenue by Type (2017-2022) & ($ million)

Table 9. Global Uric Acid Drug Revenue Market Share by Type (2017-2022)

Table 10. Global Uric Acid Drug Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Uric Acid Drug Sales by Application (2017-2022) & (K Units)

Table 12. Global Uric Acid Drug Sales Market Share by Application (2017-2022)

Table 13. Global Uric Acid Drug Revenue by Application (2017-2022)

Table 14. Global Uric Acid Drug Revenue Market Share by Application (2017-2022)

Table 15. Global Uric Acid Drug Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Uric Acid Drug Sales by Company (2020-2022) & (K Units)

Table 17. Global Uric Acid Drug Sales Market Share by Company (2020-2022)

Table 18. Global Uric Acid Drug Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Uric Acid Drug Revenue Market Share by Company (2020-2022)

Table 20. Global Uric Acid Drug Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Uric Acid Drug Producing Area Distribution and Sales Area

Table 22. Players Uric Acid Drug Products Offered

Table 23. Uric Acid Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Uric Acid Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Uric Acid Drug Sales Market Share Geographic Region (2017-2022)

Table 28. Global Uric Acid Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Uric Acid Drug Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Uric Acid Drug Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Uric Acid Drug Sales Market Share by Country/Region (2017-2022)

Table 32. Global Uric Acid Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Uric Acid Drug Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Uric Acid Drug Sales by Country (2017-2022) & (K Units)

Table 35. Americas Uric Acid Drug Sales Market Share by Country (2017-2022)

Table 36. Americas Uric Acid Drug Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Uric Acid Drug Revenue Market Share by Country (2017-2022)

Table 38. Americas Uric Acid Drug Sales by Type (2017-2022) & (K Units)

Table 39. Americas Uric Acid Drug Sales Market Share by Type (2017-2022)

Table 40. Americas Uric Acid Drug Sales by Application (2017-2022) & (K Units)

Table 41. Americas Uric Acid Drug Sales Market Share by Application (2017-2022)

Table 42. APAC Uric Acid Drug Sales by Region (2017-2022) & (K Units)

Table 43. APAC Uric Acid Drug Sales Market Share by Region (2017-2022)

Table 44. APAC Uric Acid Drug Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Uric Acid Drug Revenue Market Share by Region (2017-2022)

Table 46. APAC Uric Acid Drug Sales by Type (2017-2022) & (K Units)

Table 47. APAC Uric Acid Drug Sales Market Share by Type (2017-2022)

Table 48. APAC Uric Acid Drug Sales by Application (2017-2022) & (K Units)

Table 49. APAC Uric Acid Drug Sales Market Share by Application (2017-2022)

Table 50. Europe Uric Acid Drug Sales by Country (2017-2022) & (K Units)

Table 51. Europe Uric Acid Drug Sales Market Share by Country (2017-2022)

Table 52. Europe Uric Acid Drug Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Uric Acid Drug Revenue Market Share by Country (2017-2022)

Table 54. Europe Uric Acid Drug Sales by Type (2017-2022) & (K Units)

Table 55. Europe Uric Acid Drug Sales Market Share by Type (2017-2022)

Table 56. Europe Uric Acid Drug Sales by Application (2017-2022) & (K Units)

Table 57. Europe Uric Acid Drug Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Uric Acid Drug Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Uric Acid Drug Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Uric Acid Drug Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Uric Acid Drug Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Uric Acid Drug Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Uric Acid Drug Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Uric Acid Drug Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Uric Acid Drug Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Uric Acid Drug

Table 67. Key Market Challenges & Risks of Uric Acid Drug

Table 68. Key Industry Trends of Uric Acid Drug

Table 69. Uric Acid Drug Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Uric Acid Drug Distributors List

Table 72. Uric Acid Drug Customer List

Table 73. Global Uric Acid Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Uric Acid Drug Sales Market Forecast by Region

Table 75. Global Uric Acid Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Uric Acid Drug Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Uric Acid Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Uric Acid Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Uric Acid Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Uric Acid Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Uric Acid Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Uric Acid Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Uric Acid Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Uric Acid Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Uric Acid Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Uric Acid Drug Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Uric Acid Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Uric Acid Drug Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Uric Acid Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Uric Acid Drug Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Uric Acid Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Uric Acid Drug Revenue Market Share Forecast by Application (2023-2028)

Table 93. AstraZeneca plc Basic Information, Uric Acid Drug Manufacturing Base, Sales Area and Its Competitors

Table 94. AstraZeneca plc Uric Acid Drug Product Offered

Table 95. AstraZeneca plc Uric Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. AstraZeneca plc Main Business

Table 97. AstraZeneca plc Latest Developments

Table 98. Boehringer Ingelheim GmbH Basic Information, Uric Acid Drug Manufacturing Base, Sales Area and Its Competitors

Table 99. Boehringer Ingelheim GmbH Uric Acid Drug Product Offered

Table 100. Boehringer Ingelheim GmbH Uric Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Boehringer Ingelheim GmbH Main Business

Table 102. Boehringer Ingelheim GmbH Latest Developments

Table 103. Teijin Pharma Ltd Basic Information, Uric Acid Drug Manufacturing Base, Sales Area and Its Competitors

Table 104. Teijin Pharma Ltd Uric Acid Drug Product Offered

Table 105. Teijin Pharma Ltd Uric Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Teijin Pharma Ltd Main Business

Table 107. Teijin Pharma Ltd Latest Developments

Table 108. Regeneron Pharmaceuticals Basic Information, Uric Acid Drug Manufacturing Base, Sales Area and Its Competitors

Table 109. Regeneron Pharmaceuticals Uric Acid Drug Product Offered

Table 110. Regeneron Pharmaceuticals Uric Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Regeneron Pharmaceuticals Main Business

Table 112. Regeneron Pharmaceuticals Latest Developments

Table 113. GlaxoSmithKline plc Basic Information, Uric Acid Drug Manufacturing Base, Sales Area and Its Competitors

Table 114. GlaxoSmithKline plc Uric Acid Drug Product Offered

Table 115. GlaxoSmithKline plc Uric Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. GlaxoSmithKline plc Main Business

Table 117. GlaxoSmithKline plc Latest Developments

Table 118. Merck & Co. Inc Basic Information, Uric Acid Drug Manufacturing Base, Sales Area and Its Competitors

Table 119. Merck & Co. Inc Uric Acid Drug Product Offered

Table 120. Merck & Co. Inc Uric Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Merck & Co. Inc Main Business

Table 122. Merck & Co. Inc Latest Developments

Table 123. Novartis AG Basic Information, Uric Acid Drug Manufacturing Base, Sales Area and Its Competitors

Table 124. Novartis AG Uric Acid Drug Product Offered

Table 125. Novartis AG Uric Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Novartis AG Main Business

Table 127. Novartis AG Latest Developments

Table 128. Savient Pharmaceuticals Basic Information, Uric Acid Drug Manufacturing Base, Sales Area and Its Competitors

Table 129. Savient Pharmaceuticals Uric Acid Drug Product Offered

Table 130. Savient Pharmaceuticals Uric Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Savient Pharmaceuticals Main Business

Table 132. Savient Pharmaceuticals Latest Developments

Table 133. Ironwood Pharmaceuticals Basic Information, Uric Acid Drug Manufacturing Base, Sales Area and Its Competitors

Table 134. Ironwood Pharmaceuticals Uric Acid Drug Product Offered

Table 135. Ironwood Pharmaceuticals Uric Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. Ironwood Pharmaceuticals Main Business

Table 137. Ironwood Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Uric Acid Drug

Figure 2. Uric Acid Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Uric Acid Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Uric Acid Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Uric Acid Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Allopurinol

Figure 10. Product Picture of Febuxostat

Figure 11. Product Picture of Probenecid

Figure 12. Global Uric Acid Drug Sales Market Share by Type in 2021

Figure 13. Global Uric Acid Drug Revenue Market Share by Type (2017-2022)

Figure 14. Uric Acid Drug Consumed in Online Pharmacies

Figure 15. Global Uric Acid Drug Market: Online Pharmacies (2017-2022) & (K Units)

Figure 16. Uric Acid Drug Consumed in Retail Pharmacies

Figure 17. Global Uric Acid Drug Market: Retail Pharmacies (2017-2022) & (K Units)

Figure 18. Uric Acid Drug Consumed in Hospital Pharmacies

Figure 19. Global Uric Acid Drug Market: Hospital Pharmacies (2017-2022) & (K Units)

Figure 20. Global Uric Acid Drug Sales Market Share by Application (2017-2022)

Figure 21. Global Uric Acid Drug Revenue Market Share by Application in 2021

Figure 22. Uric Acid Drug Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Uric Acid Drug Revenue Market Share by Company in 2021

Figure 24. Global Uric Acid Drug Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Uric Acid Drug Revenue Market Share by Geographic Region in 2021

Figure 26. Global Uric Acid Drug Sales Market Share by Region (2017-2022)

Figure 27. Global Uric Acid Drug Revenue Market Share by Country/Region in 2021

Figure 28. Americas Uric Acid Drug Sales 2017-2022 (K Units)

Figure 29. Americas Uric Acid Drug Revenue 2017-2022 ($ Millions)

Figure 30. APAC Uric Acid Drug Sales 2017-2022 (K Units)

Figure 31. APAC Uric Acid Drug Revenue 2017-2022 ($ Millions)

Figure 32. Europe Uric Acid Drug Sales 2017-2022 (K Units)

Figure 33. Europe Uric Acid Drug Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Uric Acid Drug Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Uric Acid Drug Revenue 2017-2022 ($ Millions)

Figure 36. Americas Uric Acid Drug Sales Market Share by Country in 2021

Figure 37. Americas Uric Acid Drug Revenue Market Share by Country in 2021

Figure 38. United States Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Uric Acid Drug Sales Market Share by Region in 2021

Figure 43. APAC Uric Acid Drug Revenue Market Share by Regions in 2021

Figure 44. China Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Uric Acid Drug Sales Market Share by Country in 2021

Figure 51. Europe Uric Acid Drug Revenue Market Share by Country in 2021

Figure 52. Germany Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Uric Acid Drug Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Uric Acid Drug Revenue Market Share by Country in 2021

Figure 59. Egypt Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Uric Acid Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Uric Acid Drug in 2021

Figure 65. Manufacturing Process Analysis of Uric Acid Drug

Figure 66. Industry Chain Structure of Uric Acid Drug

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390